Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

A novel approach to predict mutations within the SARS-CoV-2 spike

A study posted recently to the bioRxiv* preprint server demonstrated that the emergence of new spike variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can be predicted.

6 Feb 2022

Detection of SARS-CoV-2 Delta variant infection in a domestic cat

The first published case describing the Delta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a domestic cat in the United States highlights the realistic scenario of spillover infections with emerging viral variants that threaten human and animal health.

6 Feb 2022

Study examines community and individual risk factors that relate to higher risk of COVID-19

Black residents of Baton Rouge and New Orleans faced twice the risk of SARS-CoV-2 infection as white residents, a study shows.

6 Feb 2022

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Researchers assess the understanding and trust of the revised COVID-19 isolation and quarantine guidance recommended by the U.S. CDC.

6 Feb 2022

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Researchers investigate the relationship between TSD and COVID-19.

6 Feb 2022

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Within only three weeks after the omicron variant was first identified among Houston Methodist patients, this variant rapidly took over and became the cause of a majority of new cases.

4 Feb 2022

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H. Chan School of Public Health.

4 Feb 2022

ESMO reiterates commitment to support "Close the care gap" campaign on World Cancer Day

ESMO, the leading professional organization for medical oncology, is joining the global community on the occasion of this year's World Cancer Day (WCD) to reiterate its strong commitment to supporting the "Close the care gap" campaign and securing greater access to care for all cancer patients, regardless of where they live, their financial situation or their lifestyle choices.

4 Feb 2022

Nurses play a critical role in reducing health misinformation

On July 15, 2021, the U.S. Surgeon General issued an urgent plea for all Americans to take part in slowing a serious threat to public health. He wasn't talking about the COVID-19 pandemic but rather the harmful effects on personal and public health caused by the infodemic – the creation and spread of an excessive amount of unreliable and false health information.

4 Feb 2022

Government announces two significant independent reviews to tackle health disparities

Plans to enable people across the country to live longer, healthier lives are moving forward with the government's announcement of leads for two significant independent reviews to tackle health disparities.

4 Feb 2022

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

If close friends and family members who contracted COVID-19 had mild cases and recovered quickly, or if they had an adverse reaction to the vaccine, your brain might convince you that you'd have the same experience.

4 Feb 2022

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Researchers from Yale University, University of Basel, University of Antwerp, CDDEP and other institutions recently published 'Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modeling study' in The Lancet Infectious Diseases.

4 Feb 2022

Younger mothers have the least intention to vaccinate children for COVID-19

Fathers older than age 34 were more open to having their child vaccinated against COVID-19, while younger Black and white mothers were the least open to it, finds a new survey of Medicaid recipients from the Brown School at Washington University in St. Louis.

4 Feb 2022

COVID-19 lockdown restrictions associated with increase in at-home drinking

Lockdown measures throughout 2020 have been linked to people in Scotland and England drinking more at home, according to new research.

4 Feb 2022

mRNA booster vaccination shown to induce robust neutralizing antibodies against SARS-CoV-2 omicron variant

Scientists recently assessed the immunogenicity of a third booster dose of COVID-19 vaccines against SARS-CoV-2 variants.

4 Feb 2022

Observational analysis of nucleocapsid and spike antibody responses post-SARS-CoV-2 infection

Scientists aimed at furthering our understanding of anti-Nucleocapsid and anti-Spike responses over time.

4 Feb 2022

The effect of SARS-CoV-2 infection on pregnant mothers, the placenta, and infants

A group of scientists focussed on assessing if SARS-CoV-2 infection causes any particular histologic change in the placenta.

4 Feb 2022

A disabled activist speaks out about feeling ‘disposable’

In early January, one of the country's top public health officials went on national television and delivered what she called "really encouraging news" on covid-19: A recent study showed that more than three-fourths of fatalities from the omicron variant of the virus occurred among people with several other medical conditions.

4 Feb 2022

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

In a new study, a team of researchers developed a hybrid vaccine for SARS-CoV-2 and influenza viruses using influenza virus-like particles (VLP).

4 Feb 2022

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

In a new study, researchers showed that 425 nm blue light can inactivate all major SARS CoV 2 variants.

4 Feb 2022

Pandemic News and Research

Further Reading

A novel approach to predict mutations within the SARS-CoV-2 spike

Detection of SARS-CoV-2 Delta variant infection in a domestic cat

Study examines community and individual risk factors that relate to higher risk of COVID-19

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

ESMO reiterates commitment to support "Close the care gap" campaign on World Cancer Day

Nurses play a critical role in reducing health misinformation

Government announces two significant independent reviews to tackle health disparities

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Younger mothers have the least intention to vaccinate children for COVID-19

COVID-19 lockdown restrictions associated with increase in at-home drinking

mRNA booster vaccination shown to induce robust neutralizing antibodies against SARS-CoV-2 omicron variant

Observational analysis of nucleocapsid and spike antibody responses post-SARS-CoV-2 infection

The effect of SARS-CoV-2 infection on pregnant mothers, the placenta, and infants

A disabled activist speaks out about feeling ‘disposable’

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Pioneering Live Cell Imaging - Yokogawa's Impact and Innovations

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Latest News